ES8706167A1 - Un procedimiento para preparar nuevos peptidos hipotensivos. - Google Patents

Un procedimiento para preparar nuevos peptidos hipotensivos.

Info

Publication number
ES8706167A1
ES8706167A1 ES540110A ES540110A ES8706167A1 ES 8706167 A1 ES8706167 A1 ES 8706167A1 ES 540110 A ES540110 A ES 540110A ES 540110 A ES540110 A ES 540110A ES 8706167 A1 ES8706167 A1 ES 8706167A1
Authority
ES
Spain
Prior art keywords
group
groups
substituted
carbazoyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES540110A
Other languages
English (en)
Other versions
ES540110A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES8706167A1 publication Critical patent/ES8706167A1/es
Publication of ES540110A0 publication Critical patent/ES540110A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301Acyclic saturated acids which can have further substituents on alkyl
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METODO DE PREPARAR NUEVOS PEPTIDOS HIPOTENSIVOS. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN UN DISOLVENTE INERTE, A UNA TEMPERATURA COMPRENDIDA ENTRE C50 Y 50JC, DURANTE UN PERIODO DE TIEMPO ENTRE 3 HORAS Y 5 DIAS, PARA OBTENER NUEVOS PEPTIDOS HIPOTENSIVOS DE FORMULA (I), DONDE R1 ES UN GRUPO DE C 1 A 4, UN SUSTITUYENTE AMINO O AMINO PROTEGIDO EN SU ATOMO DE CARBONO A, Y UN SUSTITUYENTE AROMATICO CARBOCICLICO, UN SUSTITUYENTE HETEROCICLICO Y OTROS; R2 ES H, UN GRUPO ALQUILO DE C 1 A 18, UN GRUPO ALQUENILO DE C 2 A 5 Y OTROS; R3 ES UN GRUPO ISOBUTILO, SEC-BUTILO Y OTROS; Y X REPRESENTA UN GRUPO DE FORMULA -CH(-A-R4)-Y.TIENEN UTILIDAD PARA EL TRATAMIENTO DE LA HIPERTENSION.
ES540110A 1984-02-03 1985-02-01 Un procedimiento para preparar nuevos peptidos hipotensivos. Expired ES8706167A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59019100A JPS60163899A (ja) 1984-02-03 1984-02-03 レニン阻害ペプチド類

Publications (2)

Publication Number Publication Date
ES8706167A1 true ES8706167A1 (es) 1987-06-01
ES540110A0 ES540110A0 (es) 1987-06-01

Family

ID=11990054

Family Applications (1)

Application Number Title Priority Date Filing Date
ES540110A Expired ES8706167A1 (es) 1984-02-03 1985-02-01 Un procedimiento para preparar nuevos peptidos hipotensivos.

Country Status (12)

Country Link
US (1) US4698329A (es)
EP (1) EP0152255A3 (es)
JP (1) JPS60163899A (es)
KR (1) KR910007576B1 (es)
CA (1) CA1267498A (es)
DK (1) DK47285A (es)
ES (1) ES8706167A1 (es)
FI (1) FI850429L (es)
HU (1) HU198951B (es)
NO (1) NO167744C (es)
PT (1) PT79917B (es)
SU (1) SU1739852A3 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613676A (en) * 1983-11-23 1986-09-23 Ciba-Geigy Corporation Substituted 5-amino-4-hydroxyvaleryl derivatives
EP0181110A3 (en) * 1984-10-22 1988-05-11 Kissei Pharmaceutical Co. Ltd. Histidine derivatives as renin inhibitors
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
EP0184855A3 (en) * 1984-12-14 1989-05-03 Abbott Laboratories Resin inhibiting compounds
EP0190891A3 (en) * 1985-01-31 1988-04-20 Kissei Pharmaceutical Co. Ltd. Novel amino acid derivatives
EP0206807A3 (en) * 1985-06-28 1988-01-20 Kissei Pharmaceutical Co. Ltd. Novel amino acid derivatives
US4853463A (en) * 1985-09-04 1989-08-01 Kissei Pharmaceutical Co., Ltd. Amino acid derivatives
US4894437A (en) * 1985-11-15 1990-01-16 The Upjohn Company Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
KR870005013A (ko) * 1985-11-29 1987-06-04 가와무라 요시부미 레닌-억제 올리고펩티드, 그의 제조방법 및 용도
US4885292A (en) * 1986-02-03 1989-12-05 E. R. Squibb & Sons, Inc. N-heterocyclic alcohol renin inhibitors
FI870474A (fi) * 1986-02-07 1987-08-08 Ciba Geigy Ag Med svavelhaltiga grupper substituerade 5-amino-4-hydroxivalerylderivat.
US4727062A (en) * 1986-03-17 1988-02-23 Merck & Co., Inc. 3-Halovinylglycine antibacterial agents
JPS6322081A (ja) * 1986-07-11 1988-01-29 Kissei Pharmaceut Co Ltd 新規なアミノ酸誘導体
DE3627877A1 (de) * 1986-07-30 1988-02-04 Hoechst Ag Renin-hemmende di- und tripeptide, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
US4814342A (en) * 1986-10-31 1989-03-21 Pfizer Inc. Nor-statine and nor-cyclostatine polypeptides
DE3640535A1 (de) * 1986-11-27 1988-06-01 Merck Patent Gmbh Peptide
ZW23187A1 (en) * 1986-12-15 1988-06-29 Hoffmann La Roche Phosphinic acid derivatives
DE3789101T2 (de) * 1986-12-19 1994-07-21 Sankyo Co Renin inhibierende Oligopeptide, ihre Präparation und ihre Anwendung.
US5032577A (en) * 1986-12-31 1991-07-16 Abbott Laboratories Peptidylaminodiols
NL8800100A (nl) * 1987-01-21 1988-08-16 Sandoz Ag Nieuwe peptidederivaten en werkwijzen voor het bereiden en toepassen van deze derivaten.
US4758584A (en) * 1987-02-05 1988-07-19 Ciba-Geigy Corporation Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
GB8707412D0 (en) * 1987-03-27 1987-04-29 Fujisawa Pharmaceutical Co Peptide compounds
US4921855A (en) * 1987-06-22 1990-05-01 Fujisawa Pharmaceutical Co., Ltd. New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same
US4859654A (en) * 1987-07-01 1989-08-22 Pfizer Inc. Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
DE68916271T2 (de) * 1988-01-26 1995-02-23 Sankyo Co Renin inhibierende Polypeptide, ihre Herstellung und Anwendung.
JPH0819153B2 (ja) * 1988-10-04 1996-02-28 キッセイ薬品工業株式会社 ペプチド誘導体
KR900012945A (ko) * 1989-02-16 1990-09-03 가와무라 요시부미 렌닌 억제활성을 갖는 펩타이트, 그 제조방법 및 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
CA1245217A (en) * 1981-12-10 1988-11-22 Joshua S. Boger Renin inhibitory peptides having phe su13 xx deletion
DE3377497D1 (en) * 1982-09-15 1988-09-01 Haessle Ab Enzyme inhibitors
AU573735B2 (en) * 1983-02-07 1988-06-23 Aktiebolaget Hassle Peptide analogue enzyme inhibitors
JPS59227851A (ja) * 1983-06-09 1984-12-21 Sankyo Co Ltd レニン阻害作用を有するペプチド類
US4613676A (en) * 1983-11-23 1986-09-23 Ciba-Geigy Corporation Substituted 5-amino-4-hydroxyvaleryl derivatives
DK110285A (da) * 1984-03-12 1985-09-13 Pfizer Polypeptider og polypeptidderivater indeholdende statin eller derivater deraf og farmaceutiske praeparater
EP0163237A3 (en) * 1984-05-29 1988-04-27 Merck & Co. Inc. Di- and tri-peptidal renin inhibitors
EP0486478A3 (en) * 1984-08-06 1992-08-12 The Upjohn Company Renin-inhibiting peptides
SU1676454A3 (ru) * 1984-11-30 1991-09-07 Санкио Компани Лимитед (Фирма) Способ получени пептидов или их фармацевтически приемлемых солей

Also Published As

Publication number Publication date
HU198951B (en) 1989-12-28
JPS60163899A (ja) 1985-08-26
KR850006008A (ko) 1985-09-28
NO167744C (no) 1991-12-04
SU1739852A3 (ru) 1992-06-07
FI850429L (fi) 1985-08-04
KR910007576B1 (ko) 1991-09-28
DK47285D0 (da) 1985-02-01
NO167744B (no) 1991-08-26
PT79917B (en) 1987-02-05
EP0152255A2 (en) 1985-08-21
EP0152255A3 (en) 1987-06-16
CA1267498A (en) 1990-04-03
PT79917A (en) 1985-03-01
FI850429A0 (fi) 1985-02-01
US4698329A (en) 1987-10-06
DK47285A (da) 1985-08-04
NO850397L (no) 1985-08-05
HUT38105A (en) 1986-04-28
ES540110A0 (es) 1987-06-01

Similar Documents

Publication Publication Date Title
ES8706167A1 (es) Un procedimiento para preparar nuevos peptidos hipotensivos.
TW251274B (es)
TW287160B (es)
ES8702437A1 (es) Procedimiento para la obtencion de tetrapeptidos sustituidos
MXPA02002505A (es) Nueva clase de agentes de citodiferenciacion e inhibidores de histona desacetilasa y metodos de utilizacion de los mismos.
ZW4294A1 (en) Heterocyclic derivatives
DK0696270T3 (da) 4-Aminofluorbenzamider og deres anvendelse som cytotoksiske promedikamenter
IT1271410B (it) Apparato per l'attivazione di combustibile impiegante un corpo magnetico
JPS56139455A (en) Sulfur-containing acylaminoacid
GR3035526T3 (en) Retroviral protease inhibitors.
AU559914B2 (en) Peptide compounds
IL110272A0 (en) Pharmaceutical combination preparations containing ras inhibitor and endothelin antagonist
DK75593D0 (es)
EP0231081A3 (en) Hydroxamic acids
AU1431188A (en) Dihydropyridine - pyridinium salt-type redox amino acids and peptides containing them
ES2002469A6 (es) Un procedimiento para la preparacion de nuevos di -.tri -. y tetrapeptidos inhibidores de renina.
EP0774462A4 (en) HETEROCYCLIC COMPOUND
ITMI922604A1 (it) Procedimento per preparare triazoloni
ATE74138T1 (de) Heptanoyl-glu-asp-ala-amino-saeureimmunstimulanten.
TW206971B (es)
EP0220923A3 (en) Dipeptides and process
DE69333270D1 (de) Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
ES8302633A1 (es) Procedimiento para eliminar el grupo n-formilo de peptidos n-formilo de peptidos n-formilados o de esteres de peptidos n-formilados.
MX9707319A (es) Acido alfa, gamma-diaminobutirico (dab) que contiene derivados oligopeptidicos.
MX9801910A (es) 2-fenilpiridinas sustituidas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519